Metrotab Vet. Flavoured 1000 mg Tablets for Dogs

País: Regne Unit

Idioma: anglès

Font: VMD (Veterinary Medicines Directorate)

ingredients actius:

Metronidazole

Disponible des:

CP Pharma Handelsgesellschaft mbH

Codi ATC:

QP51AA01

Designació comuna internacional (DCI):

Metronidazole

formulario farmacéutico:

Tablet

tipo de receta:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapéutico:

Cats, Dogs

Área terapéutica:

Antimicrobial

Estat d'Autorització:

Authorized

Data d'autorització:

2021-05-20

Fitxa tècnica

Revised: October 2023
AN: 01657/2023 & 01658/2023
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Metrotab vet. Flavoured 1000 mg Tablets for dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Metronidazole
1000 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Off-white to light brown with brown spots, round and convex flavoured
tablet with a
cross-shaped break line on one side.
The tablets can be divided into 2 or 4 equal parts.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of gastrointestinal tract infections caused by _Giardia
_spp. and _Clostridia _
spp. (i.e. _C. perfringens _or _C. difficile_).
Treatment of infections of the urogenital tract, oral cavity, throat
and skin caused by
obligate anaerobic bacteria (e.g. _Clostridia _spp.) susceptible to
metronidazole.
4.3
CONTRAINDICATIONS
Do not use in cases of hepatic disorders.
Do not use in known cases of hypersensitivity to the active substance
or to any of the
excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: October 2023
AN: 01657/2023 & 01658/2023
Page 2 of 6
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Due to the likely variability (time, geographical) in the occurrence
of metronidazole
resistant bacteria, bacteriological sampling and susceptibility
testing are
recommended.
Whenever possible, the product should only be used based on
susceptibility testing.
Official, national and regional antimicrobial policies should be taken
into account
when the veterinary medicinal product is used.
Especially after prolonged treatment with metronidazole neurological
signs could
occur.
As tablets are flavoured, store tablets out of reach of the animals in
order to avoid
accidental ingestion.
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals
Metronidazole has confirmed mutageni